AI × BIOANALYTICAL · TRACKER · v0.1

The machine
is learning
the biomolecule.

A living, curated map of how AI is transforming the design and discovery of therapeutically and commercially relevant biomolecules: proteins, antibodies, mRNA, enzymes, and the foundation models behind them.

158
tools indexed
13
domains
34
labs · companies
0
signals · 7d
CHAINA · 142 aa
METHODRFdiffusion · v3
pLDDT88.2
ROT000°
RES α: 64RES β: 28LOOP: 50ΔG: -7.4
§ 01 / Landscape

A topology of what AI is touching in biology.

Updated · live
7 domains · 26 models
Landscape · all domains
26 models · 15 organizations · ⌀ impact 7.1
ModelTargetLab · co
PROTEIN STRUCTUREAlphaFold3ESMFoldBoltz-1Chai-1OpenFold2ANTIBODY · BINDERRFdiffusion-AAChromaIgLMAbMPNNENZYME ENGINEERINGESM-3ZymCTRLEnzymeFlowMRNA · NUCLEIC ACIDRhoFold+RiNALMoLinearDesign-AIFOUNDATION MODELSESM-3Evo-2scGPTGeneformerPromoterDiffMolEWET-LAB AUTOMATIONCoscientistBioPlannerReactome-LMCLINICAL TRANSLATIONClinicalT5MedGemini
§ 02 / Signals

The pipeline reads everything. I review what matters.

Ingestion · live
arXiv · bioRxiv · journals · blogs · github
tags
9.4
IMPACT
arXivProtein structure

AlphaFold 3 extension predicts protein–RNA co-folds with single-residue accuracy.

Iso-AF folds protein–RNA complexes end-to-end. Beats diffusion baselines on PDB-Held-Out by 14% mean-pLDDT, with usable accuracy on previously unannotated riboswitches.

multimerrna-bindingiso-af
14m agoreviewing
8.7
IMPACT
bioRxivAntibody · binder

RFdiffusion-AA generates de novo nanobody binders to GPCRs with 32% wet-lab hit rate.

All-atom diffusion samples binders against three GPCR targets. 32% of designs show µM affinity in SPR; 4 candidates progress to crystallography.

nanobodygpcrde-novo
2h agoapproved
8.2
IMPACT
NatureFoundation models

ESM-3 family scales to 98B parameters; emergent zero-shot enzyme function prediction.

Largest released checkpoint shows non-linear gains on EC-number prediction without fine-tuning. Public access via API; weights restricted to academic.

scalingesmenzyme
5h agoapproved
7.9
IMPACT
GitHubmRNA · nucleic acid

LinearDesign-AI v2 ships joint CDS + UTR optimization with stability constraints.

New release jointly optimizes codon usage and 5′/3′ UTR secondary structure for expression × stability. Reproduces a published vaccine candidate to within 6% of empirical yield.

mrnacodon-optutr
11h agopending
7.6
IMPACT
BlogWet-lab automation

Coscientist-2: LLM agent runs a 14-day DBTL loop on a cloud lab without human intervention.

Agent plans, dispatches, and revises directed-evolution rounds via the Emerald Cloud API. Reports 3.4× improvement over manual baseline; failure modes analyzed in detail.

agentdbtlcloud-lab
1d agoapproved
7.2
IMPACT
arXivEnzyme engineering

ZymCTRL-Diff samples thermostable variants conditioned on EC class and Tm target.

Conditional diffusion over sequence space, anchored to a Tm regressor. 18/24 designed variants surpass parent ΔTm > 8°C with retained activity.

diffusionthermostabilityec-conditioned
1d agoapproved
6.9
IMPACT
PressClinical translation

Insilico advances AI-designed TNIK inhibitor to Phase 2a for IPF.

INS018_055, designed via a generative + reinforcement pipeline, enters Phase 2a with 60 patients enrolled. First fully AI-designed Phase 2 candidate disclosed in IPF.

clinicalipfsmall-molecule
2d agoapproved
6.4
IMPACT
arXivFoundation models

Evo-2 trains on 9.3T nucleotides; single-base mutation effect prediction across kingdoms.

Arc Institute releases sequence-only foundation model trained on metagenomic corpus. Strong zero-shot DMS performance; weights and training pipeline open.

dna-lmmetagenomeopen-weights
3d agoapproved
§ 03 / Network

Who builds what, against which target.

Companies × Models × Targets
ModelTargetCompany · Lab
Selected
Tap a node
· · ·
§ 04 / Domains

13 fronts where the stack is changing.

13 domains · curated
01 / FOUNDATION MODELS FOR BIOLOGY

Foundation Models for Biology

Foundation Models for Biology (the architectural shift underlying everything else)

22tools1impact
02 / STRUCTURE PREDICTION

Structure Prediction

26 tracked tools across this domain. Click through for the subdomain breakdown.

26tools2impact
03 / DE NOVO BIOMOLECULE DESIGN

De Novo Biomolecule Design

25 tracked tools across this domain. Click through for the subdomain breakdown.

25tools3impact
04 / DRUG DISCOVERY

Drug Discovery

Drug Discovery (Small Molecules)

17tools4impact
05 / CELLULAR & SYSTEMS MODELING

Cellular & Systems Modeling

Cellular & Systems Modeling ("Virtual Cells")

24tools5impact
06 / FUNCTIONAL GENOMICS & VARIANT EFFECT
DESIGNBUILDTEST

Functional Genomics & Variant Effect

12 tracked tools across this domain. Click through for the subdomain breakdown.

12tools6impact
07 / MASS SPECTROMETRY, PROTEOMICS, & ANALYTICAL CHEMISTRY AI

Mass Spectrometry, Proteomics, & Analytical Chemistry AI

19 tracked tools across this domain. Click through for the subdomain breakdown.

19tools7impact
08 / SPECIALIZED THERAPEUTIC MODALITIES

Specialized Therapeutic Modalities

9 tracked tools across this domain. Click through for the subdomain breakdown.

9tools8impact
09 / LAB AUTOMATION & SELF-DRIVING LABS

Lab Automation & Self-Driving Labs

0 tracked tools across this domain. Click through for the subdomain breakdown.

0tools9impact
10 / THE INDUSTRY LANDSCAPE

The Industry Landscape

8 tracked tools across this domain. Click through for the subdomain breakdown.

8tools10impact
11 / HONEST LIMITATIONS & SKEPTICISM

Honest Limitations & Skepticism

0 tracked tools across this domain. Click through for the subdomain breakdown.

0tools11impact
12 / CATCH-UP RESOURCES FOR SOMEONE COMING BACK TO THE FIELD
DESIGNBUILDTEST

Catch-Up Resources for Someone Coming Back to the Field

15 tracked tools across this domain. Click through for the subdomain breakdown.

15tools12impact
13 / THE PATTERN RECOGNITION FOR YOUR FRUSTRATION

The Pattern Recognition for Your Frustration

0 tracked tools across this domain. Click through for the subdomain breakdown.

0tools13impact
subscribe

Weekly signals in your inbox.

One short email a week with the highest-impact approved findings. No tracking, no spam.

Also available as RSS / Atom.